Clinical Trials Update:&nbsp;Jan. 27, 2005
4422
(HealthDayNews) -- Here are the latest clinical trials, courtesy of CenterWatch:
319964
The embattled pharmaceutical industry announced its intention Thursday to publish more data about clinical drug trials, despite skepticism about whether the initiative will really increase transparency and improve drug safety.
466191
roundup Plus: .Mac customers suffer e-mail glitches...Alvarion expands wireless broadband in China...IBM launches business research group.
306233
THURSDAY, July 5 (HealthDay News) -- New research suggests that the timing of when a woman receives the breast cancer drug Herceptin can influence its effect on her heart.
539492
Neurocrine updates investors on the status of its top drugs.
583563
a widely prescribed arthritis treatment - more than doubled patients&#39; risk of heart problems in a clinical study. The announcement, 11 weeks after Merck &amp; Co.
417456
roundup Plus: .Mac customers suffer e-mail glitches...IBM launches business research group...Verbatim to make discs with HP labeling feature.
449481
An IBM study expects viruses to crawl into cars and cell phones. Also:  Research finds more people banking online and the trend growing.... The Medicare budget swells past expectations.... and more.
208400
A late-stage trial of Nexavar in patients with nonsmall-cell lung cancer after a committee said it would not meet the main goal of improving overall survival.
414602
Stock falls on news treatment failed a mid-stage trial, company will cease developing drug. NEW YORK  - AtheroGenics Inc.
371936
roundup Plus: Siebel moves toward self-repairing software...Monster says it could enter Japan by mid-2005...Novell to release Open Enterprise Server.
442213
THURSDAY, Sept. 21 (HealthDay News) -- Some bad news has emerged from a study of an enzyme that is a major target in the effort to find new drugs to fight Alzheimer's disease.
61937
NEW YORK - Johnson &amp; Johnson and Boston Scientific Corp. reported new safety data yesterday for drug-coated stents that may help revive sales depressed by prior reports linking the devices to a higher risk of heart attacks.
370141
FRIDAY, Jan. 11 (HealthDay News) -- Therapeutic vaccines to fight ovarian and breast cancer are in the first stage of clinical trials to determine their safety and effectiveness, researchers report.
511748
Northfield announces clinical trial results that investors can learn from.
388102
Pre-clinical trial results are mixed, but mark a major step forward for developing human treatments.
693379
questions over testing of a key HIV/AIDS drug before a US-backed roll-out of the treatment across the continent. Ingelheim to hide adverse effects of nevirapine when used to try to prevent mother-to-child HIV transmission.